These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18586688)

  • 1. Cellular distributions of molecules with altered expression specific to the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
    Takahashi M; Shibutani M; Woo GH; Inoue K; Fujimoto H; Igarashi K; Kanno J; Hirose M; Nishikawa A
    Carcinogenesis; 2008 Nov; 29(11):2218-26. PubMed ID: 18586688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of GST-P-positive proliferative lesions facilitating lipid peroxidation with possible involvement of transferrin receptor up-regulation and ceruloplasmin down-regulation from the early stage of liver tumor promotion in rats.
    Mizukami S; Ichimura R; Kemmochi S; Taniai E; Shimamoto K; Ohishi T; Takahashi M; Mitsumori K; Shibutani M
    Arch Toxicol; 2010 Apr; 84(4):319-31. PubMed ID: 20091025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of Smad-dependent signaling for growth of GST-P-positive lesions from the early stage in a rat two-stage hepatocarcinogenesis model.
    Ichimura R; Mizukami S; Takahashi M; Taniai E; Kemmochi S; Mitsumori K; Shibutani M
    Toxicol Appl Pharmacol; 2010 Aug; 246(3):128-40. PubMed ID: 20423715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor promotion by copper-overloading and its enhancement by excess iron accumulation involving oxidative stress responses in the early stage of a rat two-stage hepatocarcinogenesis model.
    Mizukami S; Ichimura R; Kemmochi S; Wang L; Taniai E; Mitsumori K; Shibutani M
    Chem Biol Interact; 2010 May; 185(3):189-201. PubMed ID: 20302851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.
    Kinoshita A; Wanibuchi H; Morimura K; Wei M; Shen J; Imaoka S; Funae Y; Fukushima S
    Carcinogenesis; 2003 Aug; 24(8):1389-99. PubMed ID: 12807726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppression effects of bilberry extracts and enzymatically modified isoquercitrin in early preneoplastic liver cell lesions induced by piperonyl butoxide promotion in a two-stage rat hepatocarcinogenesis model.
    Hara S; Morita R; Ogawa T; Segawa R; Takimoto N; Suzuki K; Hamadate N; Hayashi SM; Odachi A; Ogiwara I; Shibusawa S; Yoshida T; Shibutani M
    Exp Toxicol Pathol; 2014 Aug; 66(5-6):225-34. PubMed ID: 24680176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Nrf2 and oxidative stress on fenofibrate-induced hepatocarcinogenesis in rats.
    Nishimura J; Dewa Y; Okamura T; Jin M; Saegusa Y; Kawai M; Umemura T; Shibutani M; Mitsumori K
    Toxicol Sci; 2008 Dec; 106(2):339-49. PubMed ID: 18775883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
    Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruptive cell cycle regulation involving epigenetic downregulation of Cdkn2a (p16(Ink4a)) in early-stage liver tumor-promotion facilitating liver cell regeneration in rats.
    Tsuchiya T; Wang L; Yafune A; Kimura M; Ohishi T; Suzuki K; Mitsumori K; Shibutani M
    Toxicology; 2012 Sep; 299(2-3):146-54. PubMed ID: 22659510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between PTEN/Akt2 and TGFbeta signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
    Taniai E; Kawai M; Dewa Y; Nishimura J; Harada T; Saegusa Y; Matsumoto S; Takahashi M; Mitsumori K; Shibutani M
    Cancer Sci; 2009 May; 100(5):813-20. PubMed ID: 19309364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered gene expression of transcriptional regulatory factors in tumor marker-positive cells during chemically induced hepatocarcinogenesis.
    Osada S; Naganawa A; Misonou M; Tsuchiya S; Tamba S; Okuno Y; Nishikawa J; Satoh K; Imagawa M; Tsujimoto G; Sugimoto Y; Nishihara T
    Toxicol Lett; 2006 Dec; 167(2):106-13. PubMed ID: 16997513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of oxidative stress in piperonyl butoxide induced hepatocarcinogenesis in rats.
    Muguruma M; Unami A; Kanki M; Kuroiwa Y; Nishimura J; Dewa Y; Umemura T; Oishi Y; Mitsumori K
    Toxicology; 2007 Jul; 236(1-2):61-75. PubMed ID: 17498859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of gene expression in different stages of MeIQx-induced rat hepatocarcinogenesis.
    Kang JS; Wanibuchi H; Murai T; Morimura K; Kinoshita A; Fukushima S
    Oncol Rep; 2007 Apr; 17(4):747-52. PubMed ID: 17342310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter-region hypermethylation and expression downregulation of Yy1 (Yin yang 1) in preneoplastic liver lesions in a thioacetamide rat hepatocarcinogenesis model.
    Abe H; Ogawa T; Wang L; Kimura M; Tanaka T; Morita R; Yoshida T; Shibutani M
    Toxicol Appl Pharmacol; 2014 Nov; 280(3):467-74. PubMed ID: 25151969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
    Steinmetz KL; Klaunig JE
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Naphthoflavone enhances oxidative stress responses and the induction of preneoplastic lesions in a diethylnitrosamine-initiated hepatocarcinogenesis model in partially hepatectomized rats.
    Dewa Y; Nishimura J; Muguruma M; Jin M; Saegusa Y; Okamura T; Tasaki M; Umemura T; Mitsumori K
    Toxicology; 2008 Feb; 244(2-3):179-89. PubMed ID: 18164116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific differences in gene expression profile revealed by cDNA microarray analysis of glutathione S-transferase placental form (GST-P) immunohistochemically positive rat liver foci and surrounding tissue.
    Suzuki S; Asamoto M; Tsujimura K; Shirai T
    Carcinogenesis; 2004 Mar; 25(3):439-43. PubMed ID: 14656948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor alpha expression as a marker for the stage of progression.
    Dragan Y; Teeguarden J; Campbell H; Hsia S; Pitot H
    Cancer Lett; 1995 Jun; 93(1):73-83. PubMed ID: 7600545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The expression of mutant p53 (mp53) protein in rat hepatic preneoplastic lesions induced by diethylnitrosamine (DEN)].
    Zhu H; Zhang X; Chen Y
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):22-4. PubMed ID: 10743048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats.
    Mukherjee B; Das T; Ghosh S; Datta S
    Eur J Cancer Prev; 2007 Aug; 16(4):363-71. PubMed ID: 17554210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.